annual shareholders equity:
-$109.27M-$129.05M(-652.38%)Summary
- As of today (August 16, 2025), AMRX annual stockholders equity is -$109.27 million, with the most recent change of -$129.05 million (-652.38%) on December 31, 2024.
- During the last 3 years, AMRX annual shareholders equity has fallen by -$469.61 million (-130.32%).
- AMRX annual shareholders equity is now -110.28% below its all-time high of $1.06 billion, reached on December 1, 2015.
Performance
AMRX Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
-$112.12M+$19.55M(+14.85%)Summary
- As of today (August 16, 2025), AMRX quarterly stockholders equity is -$112.12 million, with the most recent change of +$19.55 million (+14.85%) on June 30, 2025.
- Over the past year, AMRX quarterly shareholders equity has dropped by -$54.65 million (-95.11%).
- AMRX quarterly shareholders equity is now -110.45% below its all-time high of $1.07 billion, reached on June 1, 2016.
Performance
AMRX quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AMRX Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -652.4% | -95.1% |
| 3 y3 years | -130.3% | -140.0% |
| 5 y5 years | -147.1% | -136.6% |
AMRX Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -130.3% | at low | -133.9% | +14.8% |
| 5 y | 5-year | -130.3% | at low | -128.7% | +14.8% |
| alltime | all time | -110.3% | +71.7% | -110.5% | +70.9% |
AMRX Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -$112.12M(-14.8%) |
| Mar 2025 | - | -$131.67M(+20.5%) |
| Dec 2024 | -$109.27M(-652.4%) | -$109.27M(+16.9%) |
| Sep 2024 | - | -$93.43M(+62.6%) |
| Jun 2024 | - | -$57.47M(-9.8%) |
| Mar 2024 | - | -$63.72M(-422.1%) |
| Dec 2023 | $19.78M(-93.4%) | $19.78M(-94.0%) |
| Sep 2023 | - | $330.86M(+4.0%) |
| Jun 2023 | - | $318.17M(+8.1%) |
| Mar 2023 | - | $294.41M(-1.3%) |
| Dec 2022 | $298.42M(-17.2%) | $298.42M(+0.3%) |
| Sep 2022 | - | $297.47M(+6.1%) |
| Jun 2022 | - | $280.33M(-28.3%) |
| Mar 2022 | - | $391.13M(+8.5%) |
| Dec 2021 | $360.34M(+18.8%) | $360.34M(+2.8%) |
| Sep 2021 | - | $350.51M(+1.3%) |
| Jun 2021 | - | $346.11M(+7.1%) |
| Mar 2021 | - | $323.01M(+6.5%) |
| Dec 2020 | $303.27M(+30.7%) | $303.27M(+0.7%) |
| Sep 2020 | - | $301.04M(-1.6%) |
| Jun 2020 | - | $306.00M(-3.9%) |
| Mar 2020 | - | $318.38M(+37.2%) |
| Dec 2019 | $232.01M(-54.0%) | $232.01M(+6.4%) |
| Sep 2019 | - | $218.00M(-52.6%) |
| Jun 2019 | - | $459.66M(-2.7%) |
| Mar 2019 | - | $472.20M(-6.4%) |
| Dec 2018 | $504.75M(-230.9%) | $504.75M(+0.7%) |
| Sep 2018 | - | $501.11M(+1.3%) |
| Jun 2018 | - | $494.50M(>+9900.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | -$385.74M(-161.8%) | -$385.74M(-161.8%) |
| Dec 2016 | $623.97M(-41.3%) | - |
| Dec 2016 | - | $623.97M(-31.0%) |
| Sep 2016 | - | $903.86M(-15.8%) |
| Jun 2016 | - | $1.07B(+0.4%) |
| Mar 2016 | - | $1.07B(+0.7%) |
| Dec 2015 | $1.06B(+19.7%) | $1.06B(+3.3%) |
| Sep 2015 | - | $1.03B(+4.1%) |
| Jun 2015 | - | $987.68M(+10.4%) |
| Mar 2015 | - | $894.33M(+0.7%) |
| Dec 2014 | $887.88M(+9.6%) | $887.88M(-0.1%) |
| Sep 2014 | - | $888.50M(+2.3%) |
| Jun 2014 | - | $868.74M(+5.3%) |
| Mar 2014 | - | $825.18M(+1.8%) |
| Dec 2013 | $810.20M(+17.2%) | $810.20M(-1.0%) |
| Sep 2013 | - | $818.70M(+0.8%) |
| Jun 2013 | - | $812.17M(+1.7%) |
| Mar 2013 | - | $798.46M(+15.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $691.10M(+14.6%) | $691.10M(+1.4%) |
| Sep 2012 | - | $681.64M(+5.0%) |
| Jun 2012 | - | $649.45M(+3.7%) |
| Mar 2012 | - | $626.33M(+3.9%) |
| Dec 2011 | $602.94M(+18.7%) | $603.01M(+4.5%) |
| Sep 2011 | - | $576.77M(+3.7%) |
| Jun 2011 | - | $556.17M(+4.4%) |
| Mar 2011 | - | $532.89M(+4.9%) |
| Dec 2010 | $507.99M(+128.8%) | $508.15M(+4.6%) |
| Sep 2010 | - | $485.61M(+19.3%) |
| Jun 2010 | - | $407.10M(+12.5%) |
| Mar 2010 | - | $361.76M(+62.8%) |
| Dec 2009 | $222.01M(+39.3%) | $222.23M(+22.9%) |
| Sep 2009 | - | $180.75M(+5.5%) |
| Jun 2009 | - | $171.26M(+5.1%) |
| Mar 2009 | - | $162.90M(+2.2%) |
| Dec 2008 | $159.40M(+18.8%) | $159.40M(+5.8%) |
| Sep 2008 | - | $150.63M(-4.9%) |
| Jun 2008 | - | $158.43M(+18.1%) |
| Dec 2007 | $134.17M(-3474.4%) | $134.17M(-3474.4%) |
| Dec 2006 | -$3.98M(-144.7%) | -$3.98M(-104.6%) |
| Dec 2005 | $8.89M(-86.6%) | - |
| Sep 2004 | - | $86.34M(+1.0%) |
| Jun 2004 | - | $85.50M(+2.6%) |
| Mar 2004 | - | $83.31M(+26.0%) |
| Dec 2003 | $66.11M(+61.0%) | $66.11M(-5.1%) |
| Sep 2003 | - | $69.63M(+16.8%) |
| Jun 2003 | - | $59.60M(+56.9%) |
| Mar 2003 | - | $37.98M(-7.5%) |
| Dec 2002 | $41.06M(-31.5%) | $41.06M(-7.4%) |
| Sep 2002 | - | $44.34M(-10.1%) |
| Jun 2002 | - | $49.33M(-3.6%) |
| Mar 2002 | - | $51.15M(-14.7%) |
| Dec 2001 | $59.95M(+1.5%) | $59.95M(-4.6%) |
| Sep 2001 | - | $62.86M(-4.0%) |
| Jun 2001 | - | $65.48M(+21.4%) |
| Mar 2001 | - | $53.96M(-8.6%) |
| Dec 2000 | $59.06M(+13.0%) | $59.06M(+21.4%) |
| Sep 2000 | - | $48.66M(-16.3%) |
| Jun 2000 | - | $58.15M(-8.0%) |
| Mar 2000 | - | $63.20M(+20.9%) |
| Dec 1999 | $52.28M(+1215.2%) | $52.28M(+696.2%) |
| Sep 1999 | - | $6.57M(-5.4%) |
| Jun 1999 | - | $6.94M(+17.7%) |
| Mar 1999 | - | $5.90M(+48.4%) |
| Dec 1998 | $3.98M | $3.98M(-10.3%) |
| Sep 1998 | - | $4.43M(-17.1%) |
| Jun 1998 | - | $5.34M(-20.2%) |
| Mar 1998 | - | $6.70M |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual stockholders equity?
The current annual shareholders equity of AMRX is -$109.27M
What is the all time high annual shareholders equity for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual stockholders equity is $1.06B
What is Amneal Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
Over the past year, AMRX annual stockholders equity has changed by -$129.05M (-652.38%)
What is Amneal Pharmaceuticals, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of AMRX is -$112.12M
What is the all time high quarterly shareholders equity for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly stockholders equity is $1.07B
What is Amneal Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?
Over the past year, AMRX quarterly stockholders equity has changed by -$54.65M (-95.11%)